IFBH Shareholders Approve All AGM Resolutions, Sanction US$0.026 Final Dividend and Expanded Capital Mandates

Bulletin Express
04/29

Hong Kong-listed IFBH Limited held its Annual General Meeting on 29 April 2026, with every resolution on the agenda securing the requisite majority by poll.

Shareholders adopted the audited consolidated financial statements for the year ended 31 December 2025 and endorsed a final tax-exempt dividend of US$0.026 per share. Both items received 206.37 million votes in favour, representing 99.79 % of votes cast.

Remuneration matters were also cleared. Payment of directors’ fees of US$88,341 (S$113,750) for FY 2025 was ratified, and total directors’ fees for FY 2026 were set at S$210,000, payable quarterly in advance. Each resolution attracted 99.79 % investor support.

Board continuity was confirmed. Executive Director Pongsakorn Pongsak was re-elected with 99.99 % approval, while Non-Executive Director Tawat Kitkungvan and Independent Non-Executive Director Supansa Kusonpattana Piriyaporn were re-elected with 99.79 % backing.

Ernst & Young LLP was re-appointed auditor, with the board authorised to fix remuneration; the motion carried with 99.79 % support.

Capital-related mandates drew strong but slightly lower backing. • A general mandate to issue up to 20 % of issued shares (excluding treasury shares) passed with 95.60 % approval. • A mandate to repurchase up to 10 % of shares gained 99.79 % support. • Extending the issue mandate by the amount of shares repurchased garnered 95.60 % approval. • Authorisation to grant awards and issue shares under the Post-IPO Share Incentive Scheme was supported by 99.66 % of votes.

A special resolution to amend the company’s Constitution achieved 99.79 % approval, comfortably surpassing the three-quarters threshold.

At the voting cut-off, IFBH had 266.67 million shares in issue, including 1.89 million treasury shares that carried no voting rights. Consequently, 264.78 million shares were eligible to vote. Tricor Investor Services Limited acted as scrutineer, and all directors attended the meeting in person.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10